Evidence map›Paper›PMID 40421345›Full record

ArticleCureus2025

Valsalva Retinopathy in a Young Patient: A Case Report.

Larissa de Oliveira Silva, Lucas Neves de Oliveira, Mateus Neves de Oliveira, Hermelino Lopes de Oliveira Neto

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Larissa de Oliveira SilvaFaculty of Medicine, Universidade Estadual de Feira de Santana, Feira de Santana, BRA.
Lucas Neves de OliveiraFaculty of Medicine, Universidade Estadual de Feira de Santana, Feira de Santana, BRA.
Mateus Neves de OliveiraFaculty of Medicine, Escola Bahiana de Medicina e Saúde Pública, Salvador, BRA.
Hermelino Lopes de Oliveira NetoOphthalmology, Universidade Estadual de Feira de Santana, Feira de Santana, BRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valsalva retinopathy (VR) is a rare condition characterized by sudden visual loss due to premacular hemorrhage caused by abrupt increases in intraocular venous pressure during the Valsalva maneuver. It primarily affects healthy young adults during activities such as weightlifting, intense exercises, vomiting, and coughing. Spontaneous hemorrhage resolution may take several months, during which dehemoglobinization occurs gradually through macrophage activity - potentially leading to chronic visual impairment. This case report discusses a 20-year-old male with sudden vision loss in the right eye after weightlifting. Initial visual acuity was counting fingers at 10 cm, with premacular hemorrhage confirmed by ocular ultrasound. Expectant management was initially chosen; however, due to the lack of improvement after 60 days, pars plana vitrectomy (PPV) was performed. Postoperatively, the patient achieved 20/20 visual acuity with no retinal abnormalities. The pathophysiology of VR involves rupture of the perifoveal capillary plexus due to increased intrathoracic pressure. The macular region is prone to hemorrhage due to the lack of firm internal limiting membrane adhesions. While spontaneous resolution is common, large hemorrhages can cause complications such as macular holes, epiretinal membrane formation, and loss of photoreceptors due to the generation of free radicals. Treatment options include laser membranotomy and PPV, with the latter being preferred for dense or persistent hemorrhages. In this case, PPV successfully restored the patient's visual acuity, underscoring the importance of timely surgical intervention when conservative management fails. Early ophthalmologic evaluation and appropriate clinical follow-up remain critical in managing VR and preserving vision.

Indexed as

acute visual losspars plana vitrectomy (ppv)premacular hemorrhageretina hemorrhagevalsalva retinopathy

Identifiers

PMID40421345
PMCPMC12105803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.